21
TITLE: Transdermal Drug Delivery Systems Activated by Physical stimuli : Techniques and Applications
AUTHORS: Carla M Lopes ; Cátia Soares;
PUBLISHED: 2015, SOURCE: Drug Designing: Open Access, VOLUME: 04, ISSUE: 03
INDEXED IN: CrossRef
IN MY: ORCID
22
TITLE: Therapeutics Delivery: Innovations Technology Approaches
AUTHORS: Carla Martins Lopes ;
PUBLISHED: 2014, SOURCE: Drug Designing: Open Access, VOLUME: 03, ISSUE: 03
INDEXED IN: CrossRef
IN MY: ORCID
23
TITLE: Application of Nanotechnology in the Agro-Food Sector  Full Text
AUTHORS: Carla Martins Lopes ; Jose Ramiro Fernandes ; Paula Martins Lopes ;
PUBLISHED: 2013, SOURCE: FOOD TECHNOLOGY AND BIOTECHNOLOGY, VOLUME: 51, ISSUE: 2
INDEXED IN: Scopus WOS
IN MY: ORCID
24
TITLE: Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: Improving antifungal activity  Full Text
AUTHORS: Mendes, AI; Silva, AC ; Catita, JAM ; Cerqueira, F; Gabriel, C; Lopes, CM ;
PUBLISHED: 2013, SOURCE: COLLOIDS AND SURFACES B-BIOINTERFACES, VOLUME: 111
INDEXED IN: Scopus WOS CrossRef Handle
IN MY: ORCID
25
TITLE: Physical and Chemical Stimuli-Responsive Drug Delivery Systems: Targeted Delivery and Main Routes of Administration
AUTHORS: Joana R Lopes; Gory Santos; Pedro Barata ; Rita Oliveira; Carla M Lopes ;
PUBLISHED: 2013, SOURCE: CURRENT PHARMACEUTICAL DESIGN, VOLUME: 19, ISSUE: 41
INDEXED IN: Scopus WOS CrossRef: 53
IN MY: ORCID
26
TITLE: Therapeutic Applications of Advanced Drug Delivery Systems
AUTHORS: Lopes, CM ; Silva, AC ;
PUBLISHED: 2013, SOURCE: CURRENT PHARMACEUTICAL DESIGN, VOLUME: 19, ISSUE: 41
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
27
TITLE: Lipid-based Nanocarriers As An Alternative for Oral Delivery of Poorly Water-Soluble Drugs: Peroral and Mucosal Routes
AUTHORS: Silva, AC ; Santos, D; Ferreira, D ; Lopes, CM ;
PUBLISHED: 2012, SOURCE: CURRENT MEDICINAL CHEMISTRY, VOLUME: 19, ISSUE: 26
INDEXED IN: Scopus WOS CrossRef: 46
IN MY: ORCID
28
TITLE: Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN)  Full Text
AUTHORS: Doktorovova, S; Shegokar, R; Martins Lopes, P ; Silva, AM ; Lopes, CM ; Mueller, RH; Souto, EB ;
PUBLISHED: 2012, SOURCE: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, VOLUME: 45, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 21
IN MY: ORCID
29
TITLE: Risperidone Release from Solid Lipid Nanoparticles (SLN): Validated HPLC Method and Modelling Kinetic Profile
AUTHORS: Silva, AC ; Lopes, CM ; Fonseca, J; Soares, ME; Santos, D; Souto, EB ; Ferreira, D ;
PUBLISHED: 2012, SOURCE: CURRENT PHARMACEUTICAL ANALYSIS, VOLUME: 8, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 16
IN MY: ORCID
30
TITLE: Cationic solid lipid nanoparticles (cSLN): Structure, stability and DNA binding capacity correlation studies
AUTHORS: Doktorovova, S; Shegokar, R; Rakovsky, E; Gonzalez Mira, E; Lopes, CM ; Silva, AM ; Martins Lopes, P ; Muller, RH; Souto, EB ;
PUBLISHED: 2011, SOURCE: INTERNATIONAL JOURNAL OF PHARMACEUTICS, VOLUME: 420, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef Handle
IN MY: ORCID
Page 3 of 5. Total results: 42.